Key Events This Week
7 Sep: Stock opens at Rs.35.62, declines 1.14%
10 Sep: Technical downgrade to Sell amid bearish momentum
11 Sep: New 52-week low of Rs.31 recorded
11 Sep: Stock closes at Rs.35.98, up 3.39% intraday but weekly decline remains

Fischer Medical Ventures Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-09-11 08:02:54Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across key indicators. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s technical landscape reveals nuanced trends that investors should carefully analyse amid ongoing market volatility.
Read full news article
Fischer Medical Ventures Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-09-10 08:02:29Fischer Medical Ventures Ltd, a small-cap player in the Commodity Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Recent technical indicators, including MACD, RSI, and moving averages, signal increasing downside pressure, reflecting the stock’s underperformance relative to benchmarks such as the Sensex.
Read full news article
Fischer Medical Ventures Ltd is Rated Sell
2026-09-08 10:10:25Fischer Medical Ventures Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Fischer Medical Ventures Ltd is Rated Sell
2026-08-28 10:10:03Fischer Medical Ventures Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article









